Form 4 for IONS IONIS PHARMACEUTICALS INC
Accepted 2024-12-26 00:00:00 ET · period of report 2024-12-23 · accession 0000874015-24-000243 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-26 | 2024-12-23 | IONS | Hayden Michael R | Dir | P - Purchase | $36.22 | +5,000 | 32.7K | +18% | +$181.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-23 | P | A | 2,500 | $36.23 | 35,219 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-23 | P | A | 2,500 | $36.20 | 32,719 | D | — | — |